These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12895300)

  • 41. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells.
    Voitkun V; Zhitkovich A; Costa M
    Nucleic Acids Res; 1998 Apr; 26(8):2024-30. PubMed ID: 9518499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
    Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
    J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA polymerase arrest by adducted trivalent chromium.
    Bridgewater LC; Manning FC; Woo ES; Patierno SR
    Mol Carcinog; 1994 Mar; 9(3):122-33. PubMed ID: 8142016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of 8-hydroxydeoxyguanosine in DNA by chromium(III) plus hydrogen peroxide and its prevention by scavengers.
    Tsou TC; Chen CL; Liu TY; Yang JL
    Carcinogenesis; 1996 Jan; 17(1):103-8. PubMed ID: 8565117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of chromium(V) in the mechanism of chromate-induced oxidative DNA damage and cancer.
    Sugden KD; Stearns DM
    J Environ Pathol Toxicol Oncol; 2000; 19(3):215-30. PubMed ID: 10983888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disproportionation and nuclease activity of bis[2-ethyl-2-hydroxybutanoato(2-)]oxochromate(V) in neutral aqueous solutions.
    Levina A; Lay PA; Dixon NE
    Inorg Chem; 2000 Feb; 39(3):385-95. PubMed ID: 11229553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arrest of replication by mammalian DNA polymerases alpha and beta caused by chromium-DNA lesions.
    Bridgewater LC; Manning FC; Patierno SR
    Mol Carcinog; 1998 Dec; 23(4):201-6. PubMed ID: 9869448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formation of modified cleavage termini from the reaction of chromium(V) with DNA.
    Sugden KD
    J Inorg Biochem; 1999; 77(3-4):177-83. PubMed ID: 10643657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
    Zhitkovich A; Song Y; Quievryn G; Voitkun V
    Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The formation of DNA cleaving species during the reduction of chromate by ascorbate.
    da Cruz Fresco P; Kortenkamp A
    Carcinogenesis; 1994 Sep; 15(9):1773-8. PubMed ID: 7923568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Studies on the effects of chromium complexes].
    Shi L
    Wei Sheng Yan Jiu; 2003 Jul; 32(4):410-2. PubMed ID: 14535115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Model reactions of Cr (VI) with DNA mediated by thiol species.
    Krepkiy D; Antholine WE; Myers C; Petering DH
    Mol Cell Biochem; 2001 Jun; 222(1-2):213-9. PubMed ID: 11678605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequence specificity of Cr(III)-DNA adduct formation in the p53 gene: NGG sequences are preferential adduct-forming sites.
    Arakawa H; Wu F; Costa M; Rom W; Tang MS
    Carcinogenesis; 2006 Mar; 27(3):639-45. PubMed ID: 16251206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions.
    O'Brien T; Mandel HG; Pritchard DE; Patierno SR
    Biochemistry; 2002 Oct; 41(41):12529-37. PubMed ID: 12369844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generation of PM2 DNA breaks in the course of reduction of chromium(VI) by glutathione.
    Kortenkamp A; Ozolins Z; Beyersmann D; O'Brien P
    Mutat Res; 1989 Feb; 216(1):19-26. PubMed ID: 2918862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ascorbate is a pro-oxidant in chromium-treated human lung cells.
    Martin BD; Schoenhard JA; Hwang JM; Sugden KD
    Mutat Res; 2006 Nov; 610(1-2):74-84. PubMed ID: 16857421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular effects of chromium compound activity].
    Woźniak K
    Postepy Hig Med Dosw; 1996; 50(4):383-94. PubMed ID: 9019747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromium(III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication in vitro.
    Snow ET; Xu LS
    Biochemistry; 1991 Nov; 30(47):11238-45. PubMed ID: 1958661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of EDTA-chelatable proteins from DNA-protein crosslinks induced by a carcinogenic chromium(VI) in cultured intact human cells.
    Mattagajasingh SN; Misra HP
    Mol Cell Biochem; 1999 Sep; 199(1-2):149-62. PubMed ID: 10544963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formation of soluble organo-chromium(III) complexes after chromate reduction in the presence of cellular organics.
    Puzon GJ; Roberts AG; Kramer DM; Xun L
    Environ Sci Technol; 2005 Apr; 39(8):2811-7. PubMed ID: 15884380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.